{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T04:07:20Z","timestamp":1745035640759,"version":"3.40.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.clindermatol.2024.12.009","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T20:54:11Z","timestamp":1734382451000},"page":"147-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lupus erythematosus and dermatomyositis"],"prefix":"10.1016","volume":"43","author":[{"given":"Sarika","family":"Ramachandran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia J.","family":"Little","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff R.","family":"Gehlhausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"unstructured":"Connective Tissue Diseases. In: Braverman IM, ed. Skin Signs of Systemic Disease. 3rd ed. Philadelphia: Saunders; 1998:123-156.","key":"10.1016\/j.clindermatol.2024.12.009_bib0001"},{"unstructured":"Dermatomyositis; Lupus Erythematosus. In: Bolognia JL, ed. Dermatology. 4th ed. Elsevier; 2018: 621-635; 607-620.","key":"10.1016\/j.clindermatol.2024.12.009_bib0002"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0003","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/rheumatology\/keq430","article-title":"Association between nail-fold capillary findings and disease activity in dermatomyositis","volume":"50","author":"Mugii","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0004","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/rheumatology\/keq407","article-title":"Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis","volume":"50","author":"Schmeling","year":"2011","journal-title":"Rheumatol"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0005","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1177\/0961203316686702","article-title":"Nailfold capillaroscopic changes in patients with systemic lupus erythematosus: correlations with disease activity, skin manifestation and nephritis","volume":"26","author":"Shenavandeh","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0006","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.mvr.2013.06.003","article-title":"EUSTAR co-authors. Nailfold capillaroscopy in systemic sclerosis: data from the EULAR scleroderma trials and research (EUSTAR) database","volume":"89","author":"Ingegnoli","year":"2013","journal-title":"Microvasc Res"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0007","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/art.1780290206","article-title":"Nailfold capillary microscopy in mixed connective tissue disease. Comparison with systemic sclerosis and systemic lupus erythematosus","volume":"29","author":"Granier","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0008","first-page":"269","article-title":"Nailfold capillaroscopy in 430 patients with rheumatoid arthritis","volume":"8","author":"Rajaei","year":"2017","journal-title":"Caspian J Intern Med"},{"issue":"6","key":"10.1016\/j.clindermatol.2024.12.009_bib0009","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/BF01828450","article-title":"Multiple Hautnekrosen bei Thrombangiitis obliterans","volume":"181","author":"K\u00f6hlmeier","year":"1941","journal-title":"Arch Dermatol Syph"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0010","first-page":"148","article-title":"Dermatite papulo squameuse atrophiante","volume":"49","author":"Degos","year":"1942","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0011","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1172-8-10","article-title":"Malignant atrophic papulosis (K\u00f6hlmeier-Degos disease) - a review","volume":"8","author":"Theodoridis","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0012","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5021\/ad.2017.29.2.215","article-title":"Degos-like lesions associated with systemic lupus erythematosus","volume":"29","author":"Jang","year":"2017","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0013","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2147\/CCID.S230081","article-title":"Degos-like lesions in association with connective tissue diseases: a report of three cases and literature review","volume":"12","author":"Stavorn","year":"2019","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0014","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archderm.1979.04010120007006","article-title":"Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset","volume":"115","author":"Sontheimer","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0015","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/0003-4819-97-5-664","article-title":"Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus","volume":"97","author":"Sontheimer","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0016","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-103-1-49","article-title":"Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy","volume":"103","author":"Reed","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0017","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archderm.1963.01590200064012","article-title":"Lupus erythematosus and erythema multiforme-like lesions. A syndrome with characteristic immunological abnormalities","volume":"88","author":"Rowell","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0018","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(61)92430-8","article-title":"Precipitating autoantibodies in Sjogren's disease","volume":"2","author":"Anderson","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0019","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF01892181","article-title":"Ro (SSA) and La (SSB) antibodies","volume":"4","author":"Alexander","year":"1981","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0020","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1191\/0961203304lu2037sa","volume":"13","author":"Ting","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0021","doi-asserted-by":"crossref","first-page":"68","DOI":"10.7326\/0003-4819-84-1-68","article-title":"Dermatomyositis and malignancy. A review of the literature","volume":"84","author":"Barnes","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0022","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00051675","article-title":"Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark","volume":"6","author":"Chow","year":"1995","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0023","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaad.2020.02.061","article-title":"Malignancy in dermatomyositis: a retrospective study of 201 patients seen at the University of Pennsylvania","volume":"83","author":"Bowerman","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0024","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/bjd.12564","article-title":"Meta-analysis of the association of dermatomyositis and polymyositis with cancer","volume":"169","author":"Wang","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0025","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.38093","article-title":"Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1\u03b3","volume":"65","author":"Fiorentino","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0026","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A novel autoantibody to a 155-kd protein is associated with dermatomyositis","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0027","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2340\/00015555-3091","article-title":"Use of anti-transcriptional intermediary factor-1 gamma autoantibody in identifying adult dermatomyositis patients with cancer: a systematic review and meta-analysis","volume":"99","author":"Best","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103464","article-title":"Clinical features of dermatomyositis patients with anti-TIF1 antibodies: a case based comprehensive review","volume":"22","author":"Kilinc","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0029","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1091\/mbc.e06-08-0747","article-title":"Dynamic regulation of p53 subnuclear localization and senescence by MORC3","volume":"18","author":"Takahashi","year":"2007","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2024.12.009_bib0031","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/cancers13081886","article-title":"Prevalence of nasopharyngeal carcinoma in patients with dermatomyositis: a systematic review and meta-analysis","volume":"13","author":"Irekeola","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X24002748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X24002748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T14:32:45Z","timestamp":1744986765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X24002748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0738081X24002748"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2024.12.009","relation":{},"ISSN":["0738-081X"],"issn-type":[{"type":"print","value":"0738-081X"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lupus erythematosus and dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2024.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}